Prosecution Insights
Last updated: November 20, 2026

Amber D Steele, USPTO Patent Examiner

Listed by the USPTO as STEELE, AMBER D

Tech Center 1600 • Art Units: 1627 1639 1645 1654 1658 1676

This examiner grants 59% of resolved cases

Analysis

STEELE, AMBER D examines applications in technology center 1600 and art unit 1627. Her profile contains 831 resolved cases, an allowance rate of 58.8%, and an interview lift of 9.6%. The median time to allowance is 1254 days. The large resolved-case record supports using these figures as a meaningful historical reference when evaluating prosecution options in the assigned art unit.

The principal listed companies are Mayo Foundation for Medical Education and Research, Arizona Board of Regents on Behalf of the University of Arizona, and Lateral Ip Pty Ltd. The recurring firms are FOLEY & LARDNER LLP, Apex Attorneys at Law, LLP, and Bay State IP, LLC. Counsel can combine the stakeholder information with the allowance and timing figures when planning interviews, amendments, and portfolio-level expectations.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.8%
Allow Rate
-1.2% vs TC avg
895
Total Applications
+9.6%
Interview Lift
1254
Avg Prosecution Days
Based on 831 resolved cases, 2023–2026

Rejection Statute Breakdown

8.2%
§101 Eligibility
20.1%
§102 Novelty
25.8%
§103 Obviousness
25.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17778306 POLYPEPTIDE INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY AND USES THEREOF Non-Final OA The Regents of the University of Michigan
18746401 ANTIMICROBIAL PEPTIDES AND METHODS OF USING SAME Non-Final OA Zoetis Services LLC
18404131 MANP Analogues Non-Final OA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
17768537 Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration Final Rejection Mayo Foundation for Medical Education and Research
18564739 Substrate-specific adhesive peptides Final Rejection HENKEL AG & CO. KGAA
18700680 A RECOMBINANT REFLECTIN NANOPARTICLE Non-Final OA NANYANG TECHNOLOGICAL UNIVERSITY
18580971 COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, COMPRISING STC-1 OR DERIVATIVE THEREOF Final Rejection INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
18265523 SCG2 NEUROPEPTIDES AND USES THEREOF Final Rejection PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17760668 Conformationally-Constrained Alpha-RGIA Analogues Final Rejection University of Utah Research Foundation
16632226 COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION Non-Final OA Duke University
18533699 COMPOSITION AND METHOD FOR PROLONG SURVIVAL OF TRANSPLANT AND RECIPIENT Non-Final OA SEOUL NATIONAL UNIVERSITY HOSPITAL
18797990 METHODS AND COMPOSITIONS FOR TREATING CANCERS AND OTHER PROLIFERATIVE DISORDERS Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18037098 VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18290872 ANTI-FUNGAL GRIFFITHSIN COMPOSITIONS AND METHODS OF USE Non-Final OA University of Louisville Research Foundation, Inc.
17396304 Growth Hormone-Releasing Hormone Antagonists and Uses Thereof Non-Final OA University of Miami
18245226 A SYSTEM TO IMPROVE HAEMOSTATIC CONTROL Non-Final OA Tissue-Link ApS

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amber D Steele's allowance rate?

58.8% of resolved applications examined by Amber D Steele were allowed (831 resolved cases), compared with 35.4% across Art Unit 1627 over the last five years.

Does an interview help with examiner Amber D Steele?

This examiner's interview lift is +9.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amber D Steele take to allow a patent?

Applications allowed by Amber D Steele took 1,254 days on average from filing to allowance.

Which art unit does examiner Amber D Steele work in?

Amber D Steele examines applications in Art Unit 1627 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month